Autolus Therapeutics (AUTL) Net Income Growth (5y) (2022 - 2025)

Autolus Therapeutics (AUTL) Net Income Growth (5y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn -
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn -
3 Akari Therapeutics 976.78 Bn 976.78 Bn -
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn
7 Belite Bio 63.06 Bn 63.06 Bn -
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn
10 Autolus Therapeutics 395.22 Mn 94.51 Mn -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -16.10%
Sep 30, 2025 -16.24%
Jun 30, 2025 -8.38%
Mar 31, 2025 -18.62%
Jun 30, 2024 -0.92%
Mar 31, 2024 -14.16%
Dec 31, 2023 -31.72%
Sep 30, 2023 -0.49%
Jun 30, 2023 -13.34%
Dec 31, 2022 -29.10%